Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology

被引:121
|
作者
Hehir, Michael K. [1 ]
Silvestri, Nicholas J. [2 ]
机构
[1] Univ Vermont, Larner Coll Med, Dept Neurosci, 1 South Prospect St, Burlington, VT 05401 USA
[2] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, 1010 Main St, Buffalo, NY 14202 USA
关键词
Myasthenia gravis; Acetylcholine receptor; Antimuscle-specific kinase; Occular; RYANODINE RECEPTOR ANTIBODIES; DIAGNOSIS; AUTOANTIBODIES; CHILDHOOD; RITUXIMAB; MANAGEMENT; CHILDREN; FEATURES; TRIAL;
D O I
10.1016/j.ncl.2018.01.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myasthenia gravis (MG) is a rare disease but the most common disorder of the neuromuscular junction. It is the prototypic autoimmune disease most commonly caused by antibodies to the acetylcholine receptor (AChR) leading to characteristic fatigable weakness of the ocular, bulbar, respiratory, axial, and limb muscles. The majority of patients with MG first present with ocular symptoms. Most patients with MG experience at least 1 exacerbation of symptoms throughout the course of their illness. This article covers the epidemiology, clinical presentation, classification, and natural history of MG.
引用
收藏
页码:253 / +
页数:9
相关论文
共 50 条
  • [21] Epidemiology of myasthenia gravis varies between clinical and immunological variants
    O'Connell, DM
    Hart, I
    Moxham, N
    Waring, DJ
    Aguirreburualde, M
    Broome, J
    Tedman, B
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 110 - 110
  • [22] Kinesitherapeutic Approach in Patient with Myasthenia Gravis - Presentation of a Clinical Case
    Mileva, Miglena
    Bogomilova, Stanislava
    Shivachev, Yani
    JOURNAL OF IMAB, 2022, 22 : 35 - 38
  • [23] Rituximab in Generalized Myasthenia Gravis
    Kundi, Samiullah
    Dimachkie, Mazen
    Pasnoor, Mamatha
    McVey, April
    Herbelin, Laura
    Barohn, Richard J.
    NEUROLOGY, 2010, 74 (09) : A92 - A93
  • [24] Development of generalized myasthenia gravis in patients with ocular myasthenia gravis - In reply
    Homel, P
    Kupersmith, MJ
    ARCHIVES OF NEUROLOGY, 2003, 60 (10) : 1492 - 1493
  • [25] PROGRESSION OF OCULAR MYASTHENIA GRAVIS TO GENERALIZED MYASTHENIA GRAVIS IN THE PEDIATRIC PATIENT
    Morris, M. E.
    Carothers, B. S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 423 - 423
  • [26] Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis
    Mee, J
    Paine, M
    Byrne, E
    King, J
    Reardon, K
    O'Day, J
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2003, 23 (04) : 251 - 255
  • [27] Epidemiology, Natural History, and Clinical Presentation of Large Vessel Ischemic Stroke
    Rennert, Robert C.
    Wali, Arvin R.
    Steinberg, Jeffrey A.
    Santiago-Dieppa, David R.
    Olson, Scott E.
    Pannell, J. Scott
    Khalessi, Alexander A.
    NEUROSURGERY, 2019, 85 : S4 - S8
  • [28] Epidemiology, genetic, natural history and clinical presentation of giant cerebral aneurysms
    Lonjon, M.
    Pennes, F.
    Sedat, J.
    Bataille, B.
    NEUROCHIRURGIE, 2015, 61 (06) : 361 - 365
  • [29] Carotid sinus syndrome: Clinical presentation, epidemiology, investigation, and natural history
    Sutton, R
    NEURALLY MEDIATED SYNCOPE: PATHOPHYSIOLOGY, INVESTIGATIONS, AND TREATMENT, 1996, 10 : 137 - 144
  • [30] Epidemiology, clinical presentation, diagnosis, natural history and screening of cluster headache
    Lanteri-Minet, Michel
    PRESSE MEDICALE, 2015, 44 (11): : 1176 - 1179